simon kroll, it's been really _ good news. 0k, professor simon kroll, it's been really good - good newsk, professor simon| kroll, it's been really good to talk to you. and we'll find out how this story — and many others — are covered in tomorrow's front pages at 10:40pm and 11:30pm this evening in the papers. 0ur guestsjoining me tonight are the daily telegraph's chief political correspondent, christopher hope, alongside the evening standard columnist and times radio presenter and former labour party adviser ayesha hazarika. the headlines on bbc news: ten million people across the uk have now had their first dose of their coronavirus vaccination, giving them some protection against the virus, but there's a way to go before lifting restrictions. the oxford vaccine scientists say they're already working on another vaccine to deal with new variants. a national clap in celebration of the life of captain sir tom moore, who died yesterday — as well as for health care workers. sport — and for a full round up, from the bbc sport center, here's chetan. thank you. hi there, good evening. manchest

with me now is professor simon kroll from imperial college london.thejoint committee on vaccination and immunisation, the body which advises the uk government on vaccination schedules and safety. he is speaking this evening in a personal capacity. thank you for being with us. let's pick up on that point about the need to tweak vaccines down the road. are you confident that we will be able to do that to counter and combat these various variants like the once we have seen, the brazilian and south african a others?- we have seen, the brazilian and south african a others? yes, i think that's going — south african a others? yes, i think that's going to _ south african a others? yes, i think that's going to be _ south african a others? yes, i think that's going to be pret _ south african a others? yes, i think that's going to be pret straight - that's going to be pret straight forward. the covid vaccines are designed on a principle which hasn't been used in the past for vaccines and we lends itself to rapid adjustment and the production of the next generat